Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib + corticosteroids for chronic GVHD
NCT03584516Phase 3Terminated
- Sponsor
- Incyte
- Start
- Jan 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of itacitinib in chronic graft-versus-host disease (cGVHD), sponsored by Incyte. Started Jan 2019; status: terminated.
02
Drugs
itacitinib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT03584516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03584516.